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Strengths and limitations of this study
 ► A multicentre study of a large number of children 
who are gastrostomy fed.
 ► Key outcomes will be determined from qualitative 
work with parents, young people and professionals.
 ► The study will use validated measures for gastro-
intestinal symptoms, nutritional intake, health and 
other outcomes, and quality of life data collection .
 ► This is an observational study with no randomis-
ation, therefore confounding and bias may be of 
concern.
AbStrACt
Introduction Increasing numbers of children require 
having all, or part, of their nutritional intake via 
gastrostomy. More parents are using home-blended meals 
to feed their children, with many reporting beneficial 
effects such as improved gastro-oesophageal reflux, less 
constipation and less distress in their child.
This study aims to identify the important outcomes of 
tube feeding in this population, compare the safety, 
outcomes and resource use of those on a home-blended 
diet compared with a formula diet and assess feasibility of 
long-term follow-up of children recruited to this study.
Methods and analyses This is a mixed methods study of 
children (aged 6 months to 18 years) who are gastrostomy 
feed dependent recruited via general, community and 
specialist paediatric and dietetic services.
Workstream 1 (WS1): a qualitative study involving 
semistructured interviews with parents (n~20) and 
young people (n~5–10), and focus groups with health 
professionals (n~25), will provide evidence of appropriate 
outcome measures and the feasibility/acceptability of 
proposed data collection methods for WS2. It will gather 
data on: desired outcomes of gastrostomy feeding, 
variability in diets and reasons; use of oral feeding; 
perceived benefits of the alternative diets, resources 
associated with gastrostomy feeding and safety issues. 
Data will be analysed using thematic analysis.
WS2: a cohort study of 300 children who are gastrostomy 
fed. Data will be collected at months 0, 9 and 18 from 
parents, children (if appropriate) and clinicians using 
standardised measures and questionnaires developed 
specifically for the study. Data collected will include 
gastrointestinal symptoms, health and other outcomes 
(child, parent), dietary intake, anthropometry, healthcare 
usage, safety outcomes and resource use. Outcomes in the 
home-blended and formula groups will be compared using 
appropriate multiple regression analyses.
Ethics and dissemination The study has been approved 
by a research ethics committee (REC reference: 19/
YH/0028). Results will be disseminated through 
publications and presentations for professionals and 
families.
Study registration number ISRCTN13977361.
IntroduCtIon
There are growing numbers of children with 
complex health conditions who are depen-
dent on medical technologies to maintain 
their health, and gastrostomy (or enteral) 
feeding is one such technology. The authors’ 
own analyses of inpatient hospital (Hospital 
Episodes Statistics, HES) data found that 
among children with life-limiting condi-
tions (LLC)1 in England, the number having 
permanent gastrostomy surgery each year 
has risen from 183 in 2000/2001 to 1004 in 
2014/2015. In 2014/2015, the total number of 
children with an LLC, aged 0–19 in England, 
who have ever had a gastrostomy was 10 154. 
This is much higher than published estimates 
of ~430 children.2
Children requiring some or all of their 
nutrition via gastrostomy tubes have a wide 
range of underlying diagnoses, including 
neurodisability, inherited metabolic diseases, 
congenital cardiac conditions, cystic fibrosis, 
gastrointestinal diseases and cancer.
At present, in the UK, the recommended 
feed for children on enteral feeding is 
commercially produced complete liquid 
nutrition (formula), prescribed by the child’s 
dietitian.3 However, there is a growing body 
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of parents who are interested in and/or choosing to 
feed their children meals they have prepared themselves 
which are then liquidised so they can be administered via 
a gastrostomy (referred to forthwith as ‘home-blended 
foods’).4–6 Parents choosing to use home-blended foods 
have reported benefits such as improved gastro-oesoph-
ageal reflux, less constipation and less distress in their 
child.7 There are also perceived psychosocial benefits: it 
may fulfil parents’ need to nurture, and the child is not 
excluded from sharing the same food as the rest of the 
family. Prescribed formula, in contrast, is regarded as a 
medical product rather than food.6
Limited research evidence8 and reports from clinicians 
suggest that the long-term use of gastrostomy feeds for 
children with complex health conditions can result in 
complications including progressive feed intolerance/gut 
failure.8 There are suggestions that a home-blended diet 
may reduce the risk of gut failure but there is currently no 
evidence to support this.
Recent national surveys of paediatric dietitians in 
the UK4 and the USA5 both found that more than half 
of respondents would recommend the use of a home-
blended diet (56% and 58%, respectively). In the UK, 
however, that recommendation was to use home-blended 
food as a supplement to formula feeds rather than their 
exclusive use.
At the same time, concerns have been raised by profes-
sional organisations, including the European Society for 
Paediatric Gastroenterology Hepatology and Nutrition 
and British Dietetic Association, about the risks associated 
with a diet of home-blended foods. These include: nutri-
tional inadequacy, microbial contamination and blockage 
of the gastrostomy tube. Policy/position statements from 
such organisations do not recommend that children 
(or adults) are fed home-blended foods through their 
gastrostomy tubes.9 Importantly, it was acknowledged in 
these guidelines that the evidence for this statement is 
low and further research is likely to have an impact on 
this recommendation.
MEthodS And AnAlySES
The research question is: What are the risks, benefits and 
resource implications for using home-blended food for 
children with gastrostomy tubes compared with currently 
recommended formula feeds?
The objectives are:
1. To identify the important outcomes of gastrosto-
my feeding for parents, young people and health 
professionals.
2. To assess the safety of home-blended diets for children 
who are gastrostomy fed compared with liquid formula 
diets.
3. To identify and quantify the benefits of home-blended 
diets compared with liquid formula feeds for children 
who are gastrostomy fed and their parents.
4. To identify and quantify the resources (family and stat-
utory services) required to support home-blended di-
ets compared with formula feeds.
5. To assess whether long-term follow-up of children 
who are gastrostomy fed is feasible using routine data 
sources.
This study will use a mixed methods exploratory 
sequential design10 with two workstreams (WS), with 
findings from WS1 informing the design and methods 
for WS2. The research team comprises clinical and 
methodological experts including applied social scien-
tists (leading WS1) and a clinical epidemiologist leading 
WS2.
Workstream 1
Design
Phenomenological qualitative research with young 
people, parents and healthcare professionals. Inter-
views (young people, parents) and focus groups (health-
care professionals) will be used to investigate views on a 
number of topics relevant to informing final decisions 
regarding the design of the cohort study in WS2 as well 
as generating ‘stand-alone’ evidence on young people’s, 
parents’ and professionals’ views about gastrostomy 
feeding and the use of home-blended diets.
Eligibility criteria
 ► Parents (n=20) of children and young people (aged 
6 months to 18 years inclusive) who are fed via a 
gastrostomy.
 ► Young people (n=5–10) aged 12–18 years currently 
using a gastrostomy and with no significant cognitive 
impairments.
 ► Health professionals who provide or support the nutri-
tional care of children with a gastrostomy, specifically 
paediatricians (n=6–8), dietitians (n=6–8), children’s 
community nurses (n=6–8) and speech and language 
therapists (n=6–8).
Sampling
Purposeful sampling will be used. Parents will be 
sampled to ensure representation of different diets 
(formula vs home blended vs mixed), dietary history (ie, 
unchanged since gastrostomy vs change of diet), range 
of children’s ages, duration of gastrostomy feeding 
and broad stance of clinicians overseeing child’s care 
regarding home-blended diets (ie, supportive vs unsup-
portive). Healthcare professionals will be sampled 
to ensure representation of the range of healthcare 
professions (eg, paediatricians, dieticians) who support 
children who are gastrostomy fed, stance on home-
blended diets and experience of supporting children 
using home-blended diets.
Recruitment
We will recruit via general, community and/or specialist 
paediatric services in English National Health Service 
(NHS) Trusts and children’s nutrition and dietetic 
services attached to, or working into, these services. 
Services will be selected to represent the broad range 
of stances regarding home-blended diets (supportive, 
neutral and unsupportive). Based on estimated numbers 
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of children using a home-blended diet we plan to recruit 
from six NHS Trusts in WS1.
For parents and young people, research staff/clini-
cians will identify eligible participants and provide the 
study team with an anonymised list, detailing sampling 
characteristics. The study team will select which partic-
ipants to approach based on sampling criteria (see the 
Eligibility Criteria section). The site research staff/
clinicians will then approach the selected participants 
in clinic or via post. Parents and young people who 
return response forms will be contacted by the study 
team and an interview time and date will be arranged.
Data collection
Individual interviews (young people, parents) and focus 
groups (professionals) will be used to collect data. 
Parents will be offered the choice of telephone or face-
to-face interview. Consent will be recorded at the start 
of the interview/focus group. For young people aged 
12–15 years, child assent and parent consent will be 
obtained.
Interview/focus group schedules will cover the 
following topics (tailored to the characteristics of the 
interviewee(s)):
 ► Typical diet followed and factors which may affect 
adherence to that diet.
 ► In terms of blended diets, factors influencing decision 
to use diet, types of food comprising diet, parental 
management of diet, support and guidance offered 
and adherence to guidance.
 ► Desired and observed immediate and longer term 
health and quality of life (QoL) outcomes (including 
unanticipated and/or undesirable) for the child of 
gastrostomy feeding and perceived impacts of the 
type of diet used.
 ► Observed symptoms associated with gastrostomy 
feeding (eg, reflux, constipation) and impacts of type 
of diet on symptoms.
 ► Perceived outcomes for parents of their child being 
fed by gastrostomy, and impacts of type of diet on 
these outcomes.
 ► Perceived/experienced risks/safety issues and other 
drawbacks associated with gastrostomy feeding, 
including the type of diet used.
 ► Reported/perceived costs to families and the NHS 
(financial, time) of using gastrostomies and the 
impact of type of diet on those costs.
In addition, interviews with parents will explore 
views regarding feasibility and acceptability (in terms 
of parent participation) of the proposed design of 
the cohort study (eg, proposed recruitment methods, 
collecting nutritional data, respondent burden and 
retention strategies).
For interviews with young people who have communi-
cation impairments, we will use their preferred commu-
nication systems and, if necessary, use or create visual 
tools (eg, Talking Mats11) to facilitate the interview.12
With participants’ permission, interviews/focus 
groups will be audio recorded and verbatim transcripts 
obtained.
Data analysis
An inductive approach to data analysis using thematic 
analysis techniques13 will be used to identify and describe 
experiences of gastrostomy feeding, ways in which blend-
ed-food diets are being implemented, outcomes that 
are important across the sample, resource implications 
and complications associated with blended feeds, and to 
examine the acceptability and appropriateness of piloted 
measurement tools.
Specifically, we will use the Framework approach14 to 
facilitate systematic data management and ensure audit 
trails of the data management process:
1. Researchers familiarise themselves with the data, and 
identify themes and key issues.
2. Based on identified themes and any a priori issues 
(eg, acceptability of proposed WS2 data collection 
tools, outcomes associated with gastrostomy feeding, 
resource use), an index of themes is constructed (the 
thematic framework).
3. Data are then indexed according to which theme(s) in 
the analytical framework they relate to. The indexed 
data from each case (eg, participant, focus group) 
are summarised onto a series of thematic matrices (or 
charts). Each chart is divided into columns, allowing 
relevant data to be organised according to subthemes/
issues. A single row on each chart holds one partici-
pant’s data. Thus, reading along a row provides an 
overview of everything an individual spoke about in 
terms of a specific issue. Reading down the chart (or 
down a column) allows comparison between partici-
pants’.
4. The final stage of analysis involves ‘reading’ of the 
charts, composing ‘analytical notes’ which describe the 
data and developing interpretation and hypotheses 
which are then tested against the charts and raw data. 
To start, data will be analysed by participant group 
after which there will be a process of comparison be-
tween groups.
Integrating WS1 findings into final decision-making regarding WS2
WS1 findings will be presented to an expert study 
steering committee (SSC) comprising parent, clinical 
and academic expertise. The SSC will be tasked, in 
discussion with the research team, with agreeing which 
outcomes to measure in WS2 and selecting appropriate 
measurement/data collection tools for these in terms 
of feasibility (eg, respondent burden) and compre-
hensiveness. Where additional outcome domains not 
included in the original protocol are identified in WS1, 
candidate outcome measures will be identified by the 
research team and presented to the SSC. The SSC will 
also review WS1 findings regarding the need to include 
further descriptive and predictor variables for WS2, and 
the team’s proposed means of collecting data on these.
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Table 1 Eligibility criteria
Eligible Ineligible
A Child is at least 6 months 
old and under 19 years.
Infants up to 6 months 
and young people who are 
19 years and older.
B Child is gastrostomy feed 
dependent.
Child has another type 
of feeding tube (eg, 
nasogastric, jejunostomy).
C Child receives most or all 
of their nutrition via the 
gastrostomy.
  
D Child is living with 
parent(s): biological or 
adoptive.
Child is not living with a 
parent (eg, in residential 
setting or foster care).
E Family resident in England. Family not resident in 
England.
Workstream 2
Design
A prospective cohort study with an initial 18-month 
follow-up period but also including an assessment of 
the potential for long-term (10 years+) follow-up using 
routine data sources to measure key outcomes for these 
children.
Eligibility criteria
Children (aged 6 months to 18 years inclusive) who 
receive most or all of their nutrition via gastrostomy 
tube. Parents of participating children will also take part 
in the study. We are including child and parent dyads in 
order to measure child and parent outcomes (eg, QoL); 
therefore, children who do not live with a biological or 
adoptive parent are not eligible to take part. The study is 
limited to families who reside in England (see table 1 for 
summary of inclusion and exclusion criteria).
Sample size
Given that no data are available on the exact propor-
tion of children who receive formula feeds versus a 
home-blended diet in England, various scenarios were 
explored to ensure that the study would be adequately 
powered. A sample size of 300 for the analysis (assuming 
there are twice as many formula fed as home blended) 
should enable us to estimate proportions within each 
group to within a margin of error of ≤10% and contin-
uous measures (eg, Pediatric Quality of Life Inventory 
(PedsQL) assuming SD 20) to within an SE of 4 points.
Recruitment
As per WS1, children and their parents will be recruited 
via general, community and/or specialist paediatric 
services in English NHS Trusts, and children’s nutrition 
and dietetic services attached to, or working into, these 
services. Based on estimated numbers of children using 
a home-blended diet we plan to recruit from around 20 
NHS Trusts. For WS2 we will also plan to recruit from 
children’s hospices in England and via social media, as 
recommended by the parent advisors for the study.
Families will be recruited primarily in routine clinic 
appointments with paediatricians or dietitians, but fami-
lies may also be invited by post, telephone and via social 
media. In WS2, families must be supported by a recruiting 
NHS Trust or children’s hospice to take part, in order for 
clinical data to be obtained in the study. In WS2, clini-
cians will introduce the study and obtain consent from 
parents and children where possible for the study team 
to contact them. Consent to participate in the study will 
be sought by the study team, with appropriate consent/
assent processes used depending on the age and capacity 
of participating children. For young adults (16–18 years), 
an assessment of capacity in line with the Mental Capacity 
Act will be undertaken by the clinician at the consent to 
contact stage.
All families will receive a full study information pack 
about the study, which will contain relevant participant 
information sheets and study consent forms depending 
on the child/young person’s capacity. For young adults 
who lack capacity, we will identify an appropriate personal 
consultee to provide advice about the young adults’ views 
and wishes about taking part in the study, using appro-
priate consultee information sheets and consultee decla-
ration forms.
Consent processes are as follows:
 ► Young adults aged 16–18 years with capacity. Young 
adults and parents will provide separate consent for 
their own participation.
 ► Young adults aged 16–18 years without capacity. No 
consent will be taken. Young adults will take part in 
the study if the consultee advises that they would not 
have any objections to taking part. Parents will consent 
separately for their own participation in the study.
 ► Children and young people aged 7–15 years who can under-
stand information about the study and express an opinion 
about taking part. Parents will provide consent and 
the child/young person will provide written or verbal 
assent. A simplified version of the assent form will be 
used for children aged 7–11 years, with a standard 
version used for young people aged 12–15 years. 
Parents will provide separate consent for their own 
participation.
 ► All other children and young people under the age of 16 years. 
Parents will consent for their child and themselves.
Data collection
Data will be collected at three time points: at baseline and 
then at 9 and 18 months. At each time point, data on a 
range of outcomes as well as relevant clinical and feeding 
information will be collected from parents/children/
young people and clinicians. See table 2 for summary of 
proposed outcomes and data sources (these are subject to 
change following WS1).
The majority of the data will be collected via parent ques-
tionnaire administered according to parent preference 
(postal vs online; parents will also be offered telephone 
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interview). Parents whose children receive home-blended 
food will also be required to provide dietary information 
via the online myfood24 tool,15 or via a paper food diary 
or telephone call with the research team if using the 
online tool is not possible. Where appropriate, partici-
pating children and young people will also be asked to 
complete a short questionnaire (eg, to self-report QoL). 
Up to three reminders via text and/or post will be used at 
each time point. A small incentive voucher of £20 will be 
provided to each family after return of the questionnaires 
at each time point.
Clinical information (eg, diagnoses, medications, 
anthropometry) will be collected from children’s paedi-
atrician and/or dietitian. Dietitians will also provide 
details about formula feeds used by participating chil-
dren. Finally, we will use routine healthcare data through 
linkage undertaken by NHS Digital to the HES data 
(inpatient, accident and emergency (A&E), outpatient) 
and the Office for National Statistics (ONS) death certif-
icate data.
Data analyses
The data quality of each data item collected will be 
assessed when the data are collected or received by 
the research team. Appropriate attempts will be made 
to obtain missing or out-of-value data. A review of the 
collected data will be undertaken after the first 25 partic-
ipants have completed baseline questionnaires to check 
for any systematic issues with the data collection.
A statistical analysis plan will be developed and signed 
off prior to analysis. Analysis will follow Strengthening the 
Reporting of Observational Studies in Epidemiology16 
and Reporting of Studies Conducted Using Observa-
tional Routinely-collected Data17 guidelines. Descriptive 
statistics of clinical and demographic characteristics of 
the study population at baseline will be used to examine 
differences between the groups of children who are 
predominantly formula fed and those who use home-
blended diets.
Children will be grouped into those who are on a 
predominantly blended diet or formula diet at baseline 
by:
 ► Home-blended group if most of their nutritional 
intake is provided via home-blended diet. This catego-
risation will be informed by WS1 and in consultation 
with the SSC.
 ► Formula fed if most of their diet comes from formula.
Most of the proposed outcome measures will require 
scoring or aggregation before the statistical modelling 
can be undertaken:
 ► The PedsQL generic scale18 and PedsQL gastroin-
testinal symptoms module19 will be scored as per the 
guidelines and transformed to a score of 0–100.
 ► The height (or length) and weight will be used to 
calculate an age and sex-adjusted body mass index 
(BMI SD score (SDS)).
 ► The myfood24 data programme analyses the nutri-
tional content of the home-blended diet and will 
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compute the calorie intake and the macro/micro-
nutrient content of the feed and any oral feeds. The 
same data for the formula fed group will have been 
obtained, via the dietitian, from the commercial 
supplier.
 ► The parent-reported number of site infections and 
other tube-related complications will be reported as 
total counts for each child.
 ► The diagnostic (International Classification of 
Diseases, Tenth Revision)20 and procedural codes 
(OPCS Classification of Interventions and Proce-
dures) in the HES data will be used to identify 
admissions which were related to complications of 
the gastrostomy tubes or infections. The number of 
admissions and A&E attendances will be calculated 
for each child. Length of stay for each admission will 
also be calculated for the resource use analyses.
 ► Parent QoL. The EuroQol-5 Dimension (EQ-5D) 
visual analogue scale is scored 0–100 and the five-com-
ponent scale of the 5-level version of EuroQol-5 
Dimension (EQ-5D-5L) will be converted to a single 
score using a UK-specific value set.21 The 10-item 
Parenting Morale Index is scored from 0 to 100.
For all outcomes we will report the baseline score, 
follow-up scores and change score.
Assessing safety (objective 2) and benefits (objective 3)
The safety and benefits of blended diet compared with 
formula diet will be assessed using multivariable regres-
sion analyses. The type of regression will depend on the 
outcome of interest: logistic (tube blockage, appropriate 
nutritional content; yes/no), linear (PedsQL gastrointes-
tinal module score, BMI SDS or upper arm circumference, 
calories, Parenting Moral Index (PMI), EQ-5D), Poisson or 
negative binomial (number of A&E or hospital admissions 
for infections or complications of gastrostomy tube). Each 
analysis will account for the multiple confounding factors in 
this population (age, underlying diagnoses, comorbidities, 
outpatient attendance, parental factors, socioeconomic 
status) and the main covariate of interest will be feeding 
status (blended vs formula). Study site will be added as a 
random effect to the models to allow for site-level variation. 
Estimates and 95% CIs will be reported from the regression 
model for each outcome measure.
The flow of participants through the study will be 
detailed including the number of individuals contrib-
uting to each analysis. The amount of missing data will 
be summarised for each outcome measure and multiple 
imputation will be used to assess the robustness of the 
results. Results will be compared with the complete case 
analyses and important differences discussed. Sensitivity 
analyses will be considered to explore departures from 
the missing at random assumption.
Measurement of cost and outcomes (objectives 3 and 4)
There is a lack of robust evidence around the cost-effec-
tiveness of alternative feeds for gastrostomy fed children. 
To address this, we will describe the costs and outcomes 
for those children with a formula diet and with a home-
blended diet (addressing objectives 3 and 4). The formula 
feed group will act as the treatment as usual.
Generating cost estimates
Unit costs for healthcare interactions will be collected 
from published sources (eg, PSSRU Unit Costs of Health 
and Social Care) and applied to the relevant resource use. 
The costs of healthcare interactions will be calculated by 
the product of unit cost and resource use analyses.
The cost of non-healthcare interactions, including the 
cost of the blended diet constituents and time taken to 
prepare, will be estimated separately using published esti-
mates where feasible. Sensitivity analyses will be conducted 
where alternative assumptions would generate substan-
tially different cost estimates (eg, if there are substantial 
differences between parental report and HES data).
Generating estimates of outcomes
We will describe and summarise estimates of parent 
changes in health-related quality of life (EQ-5D-5L) and 
child (either PedsQL or QoL questionnaire22). We will 
describe these for both groups within the cohort.
We will report total costs, mortality and adverse event 
rates associated with both home-blended and formula 
feeds in a cost-consequences framework.
Long-term follow up (objective 5)
The utility of routine data sources as an option for long-
term follow-up of study participants will be assessed by 
examining the concordance between parent-reported 
data on A&E visits and hospital admissions due to infec-
tions or complications of their gastrostomy tube with HES 
data for the corresponding time period. Concordance 
will be assessed using the kappa statistic both for the total 
sample and separately by the home-blended and formula 
fed groups.
If there is concordance between the parental reported 
infection and gastrostomy-related healthcare usage and 
HES data, long-term follow-up would be possible by 
obtaining further extracts of HES data and ONS death 
certificate data. The HES data will provide future infor-
mation on admissions and A&E visits due to infections 
and complications of the gastrostomy (blockages, revi-
sions, replacements). The ONS data will provide date and 
cause(s) of death if the child has died.
Patient and public involvement
Six parents whose children were gastrostomy fed were 
involved in the development of the study design and 
methods, and plans for public involvement. In particular, 
they helped to identify outcomes to propose for WS2, 
develop appropriate recruitment methods for both WS 
(eg, recommended that we use social media) and they 
chose the study title ‘Your Tube’.
During the study, our primary mechanism for 
public involvement will be via a Project Advisory Panel 
comprising four to five parents and two to three young 
people with gastrostomy experience. The panel will meet 
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twice per year at key points in the study, and be involved 
at other times when needed via telephone, email or in 
person depending on the task. Panel members will be 
supported by the study team, and receive training for 
specific tasks when needed.
Members of the panel will be involved in the following:
Study oversight: a minimum of two members of the panel 
will also be members of the SSC.
Developing study materials: reviewing participant infor-
mation sheets, consent forms and interview schedules; 
piloting of WS1 topic guides and materials; development 
of guidance for parents taking part in WS2; piloting of 
WS2 questionnaires and data collection tools.
WS2 study design: selection of outcomes to be included 
in WS2, and input on the acceptability and feasibility of 
proposed measurement tools.
Study interpretation: input on the meaning of study find-
ings, and development of key messages for policy and 
practice
Study dissemination: help to produce information 
resources for parents, children and young people at the 
end of the study; identify routes for dissemination and 
assist in the dissemination of the study outputs directly via 
their own networks.
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